Get the Stockscreener App
44.39
3.18%
-1.46
After Hours:
44.15
-0.24
-0.54%
Medline Inc stock is traded at $44.39, with a volume of 4.44M.
It is down -3.18% in the last 24 hours and down -0.74% over the past month.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
See More
Previous Close:
$45.85
Open:
$43.55
24h Volume:
4.44M
Relative Volume:
1.30
Market Cap:
$36.02B
Revenue:
$27.43B
Net Income/Loss:
$1.27B
P/E Ratio:
28.04
EPS:
1.5829
Net Cash Flow:
$1.01B
1W Performance:
-11.20%
1M Performance:
-0.74%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$42.60
$44.95
1-Week Range:
$42.60
$50.88
52-Week Range:
$38.50
$50.88
Medline Inc Stock (MDLN) Company Profile
Name
Medline Inc
Sector
Industry
Phone
847-949-3000
Address
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
44.39 | 37.20B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ISRG
Intuitive Surgical Inc
|
497.42 | 176.23B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
174.21 | 50.22B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.08 | 41.28B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.28 | 37.50B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-26 | Initiated | Tigress Financial | Buy |
| Jan-21-26 | Reiterated | BTIG Research | Buy |
| Jan-12-26 | Initiated | Citigroup | Buy |
| Jan-12-26 | Initiated | Deutsche Bank | Hold |
| Jan-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-12-26 | Initiated | Goldman | Buy |
| Jan-12-26 | Initiated | JP Morgan | Overweight |
| Jan-12-26 | Initiated | Jefferies | Buy |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-12-26 | Initiated | Mizuho | Outperform |
| Jan-12-26 | Initiated | Morgan Stanley | Overweight |
| Jan-12-26 | Initiated | Piper Sandler | Overweight |
| Jan-12-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-12-26 | Initiated | Robert W. Baird | Outperform |
| Jan-12-26 | Initiated | Rothschild & Co Redburn | Neutral |
| Jan-12-26 | Initiated | Stifel | Buy |
| Jan-12-26 | Initiated | TD Cowen | Buy |
| Jan-12-26 | Initiated | Truist | Buy |
| Jan-12-26 | Initiated | UBS | Buy |
| Jan-12-26 | Initiated | Wells Fargo | Equal Weight |
| Jan-12-26 | Initiated | William Blair | Outperform |
| Jan-12-26 | Initiated | Wolfe Research | Outperform |
View All
Medline Inc Stock (MDLN) Latest News
Medline’s PE backers start stake sale worth $3.4 billion - Crain's Chicago Business
Medline’s PE Backers Start Stake Sale Worth $3.4 Billion - Bloomberg.com
Medline stockholders launch 75 million share offering - Investing.com
Medline shares fall 4.4% as major investors launch secondary offering By Investing.com - Investing.com Canada
Medline announces $3.6B secondary offering from private equity firms - MassDevice
Medline Inc. announces launch of secondary offering of Class A common stock - Yahoo Finance
Medline expands AI platform and warehouse robotics - Digital Commerce 360
Medline Inc.: Fundamental Analysis and Financial Ratings | MDLN | US58507V1070 - marketscreener.com
The Analyst Verdict: Medline In The Eyes Of 29 Experts - Benzinga
Wells Fargo & Company Increases Medline (NASDAQ:MDLN) Price Target to $47.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... By GuruFocus - Investing.com Canada
Medline Analysts Boost Their Forecasts Following Q4 Results - Benzinga
Medline (NASDAQ:MDLN) Given New $54.00 Price Target at BMO Capital Markets - MarketBeat
Wolfe Research raises Medline stock price target on revenue beat By Investing.com - Investing.com India
CEO of Northfield-based Medline talks tariffs, IPO following company’s first earnings call - Chicago Tribune
Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… - marketscreener.com
Evercore ISI Maintains Outperform on Medline Inc (MDLN) Feb 25 2026 - Meyka
Medline's first quarter as a public company ends with rising sales, dip in income - Crain's Chicago Business
Medline Inc. SEC 10-K Report - TradingView
Stifel raises Medline stock price target to $55 on strong results - Investing.com
Medline Q4 Earnings Call Highlights - MarketBeat
Evercore ISI raises Medline stock price target on strong momentum By Investing.com - Investing.com South Africa
Evercore ISI raises Medline stock price target on strong momentum - Investing.com
Robust Q4 Beat and Underappreciated 2026 Upside Support Buy Rating on Medline - TipRanks
Earnings call transcript: Medline Q4 2025 sees strong sales growth, stock dips - Investing.com
Medline: Q4 Financial Overview - Bitget
Medline reports growth in Q4 despite earnings shortcomings - MassDevice
Medline Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:MDLN) 2026-02-25 - Seeking Alpha
Medline reports Q4 EPS (1c), consensus 13c - TipRanks
Medline: Q4 Earnings Snapshot - Clinton Herald
Medline Inc. Reports Fourth Quarter and Full Year 2025 Results - TradingView
Medline Reports Fourth Quarter and Full Year 2025 Results - The Manila Times
Earnings Flash (MDLN) Medline Inc. Reports Q4 Revenue $7.79B, vs. FactSet Est of $7.51B - marketscreener.com
Medline Is a Medical-Surgical Powerhouse, and We Expect Durable Earnings Growth Through 2030 - Morningstar
Assessing Medline (MDLN) Valuation After Recent Share Price Momentum - Yahoo Finance
Medline Inc. Q4 2025 earnings preview - MSN
Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy? - Yahoo Finance
Should I buy Medline Inc. (MDLN) - Zacks Investment Research
A Look Into Medline Inc's Price Over Earnings - Benzinga
Medline Inc expected to post earnings of 25 cents a shareEarnings Preview - TradingView
Medline Inc (MDLN) Shares Up 3.66% on Feb 20 - GuruFocus
Medline to debut enhanced Ankle Fracture and Foot Reconstruction Plating Systems at ACFAS 2026 Annual Scientific Conference - Medline Newsroom
Launching Coverage on Medline, a Medical-Surgical Giant, With a $45 Fair Value and a Narrow Moat - Morningstar
Medline (NASDAQ:MDLN) Sets New 1-Year HighShould You Buy? - MarketBeat
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference - GlobeNewswire
MSN Money - MSN
Medline Inc. (MDLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
FDA Flags Serious Safety Fire Risks In Medline Homecare Beds - Benzinga
Is It Too Late To Consider Medline (MDLN) After Its Recent Share Price Rally? - Yahoo Finance
Medline stock pops 40% in first trading session after company raises $6.3 billion in 2025's biggest IPO - AOL.com
Medline Inc Stock (MDLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):